Multinational Pharmas: Expect Key Policy Shifts In China
The China Food and Drug Administration ("CFDA") recently announced the Draft Amendment of the Measures on the Administration of Drug Registration (also known as the Drug Registration Rules, "DRR" or DRR Draft...To view the full article, register now.
Already a subscriber? Click here to view full article